BioAtla, Inc. — Director's Dealing 2022

Sep 20, 2022

SEC Form 4/A — Form 4/A

Issuer: BioAtla, Inc. (BCAB)
CIK: 0001826892
Period of Report: 2022-09-12

Reporting Person: MCBRINN SYLVIA (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	3425	Direct

Footnotes

F1: This Amendment to the original Form 4 filed on September 15, 2022 is being filed to reflect the corrected amount of Common Stock shares held directly by the Reporting Person after the reported transactions following the filing of an amendment to the Reporting Person's Form 3 which corrected the amount of Common Stock shares held directly.